Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors
Chronic itch affects about 10% of the general population, however current treatments are largely ineffective. Here, the authors show that targeting of inhibitory α2 and α3GABAA receptors reduces itch in mice and in a canine model, suggesting this a potentially useful therapeutic approach.
Guardado en:
Autores principales: | William T. Ralvenius, Elena Neumann, Martina Pagani, Mario A. Acuña, Hendrik Wildner, Dietmar Benke, Nina Fischer, Ana Rostaher, Simon Schwager, Michael Detmar, Katrin Frauenknecht, Adriano Aguzzi, Jed Lee Hubbs, Uwe Rudolph, Claude Favrot, Hanns Ulrich Zeilhofer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8993328b421e431ca678a24d0b1b96fb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Enhancing neuronal chloride extrusion rescues α2/α3 GABAA-mediated analgesia in neuropathic pain
por: Louis-Etienne Lorenzo, et al.
Publicado: (2020) -
Developmental seizures and mortality result from reducing GABAA receptor α2-subunit interaction with collybistin
por: Rochelle M. Hines, et al.
Publicado: (2018) -
Dendrite-targeting interneurons control synaptic NMDA-receptor activation via nonlinear α5-GABAA receptors
por: Jan M. Schulz, et al.
Publicado: (2018) -
Neuron-specific spinal cord translatomes reveal a neuropeptide code for mouse dorsal horn excitatory neurons
por: Rebecca Rani Das Gupta, et al.
Publicado: (2021) -
An itching plaque
por: Juan Garcias-Ladaria, et al.
Publicado: (2015)